IFNG and cancer: IFNγ secretion triggers the expression of indoleamine 2, 3-dioxygenase 1 (IDO1) in cancer cells, an enzyme that catabolizes Trp to generate metabolites that induce effector T cell dysfunction (135, 136, 137).